Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Diabetes Metab ; 31(5): 457-62, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16357789

RESUMO

OBJECTIVE: To study the patterns of hypoglycaemic treatment in our community and to estimate the prevalence of known and drug-treated diabetes mellitus. METHODS: From all the diabetic patients who attended the Healthcare Centers of the National Health Service in Gran Canaria in 1999, a random sample of 2924 diabetic patients > 20 years old was selected. Data on age, gender, clinical onset of diabetes, and hypoglycaemic treatment were obtained. Data on drug consumption were supplied by the National Health Service. RESULTS: Of the DM-2 patients 4.4% (3.65-5.14) 84.2% (82.7785.42), 9.4% (8.34-10.45) and 2.1% (1.58-2.61) received diet only, oral drugs, insulin or combination. The duration of DM-2 was associated with more oral drugs and more insulin treatment, but the duration of DM-1 was not associated with intensive insulin therapy;<50% of the type 1 patients had >or=3 daily injections. The prescriptions of biguanides were scarce; over 1/3 of them were of buformin. DM-1 and DM-2 patients were treated with similar doses of insulin, but DM-1 patients had more insulin injections (2.56 vs 2.07, P<0.001), and more fast-acting insulins (65.2% vs 38.0%, P<0.001). The estimated prevalences of known and drug-treated diabetes in the Gran Canaria island were 5.95% (95% CI: 5.096.80%) and 5.73% (4.88-6.57%). CONCLUSIONS: Our prevalences of known and drug-treated diabetes is among the highest reported in European populations. The prescriptions of metformin and of combined therapy in DM-2, and of intensive insulin therapy in DM-1 are less frequent than expected, but nonetheless insulin therapy in DM-1 is more intensive and uses more fast-acting insulin than in DM-2.


Assuntos
Diabetes Mellitus/epidemiologia , Prescrições de Medicamentos/estatística & dados numéricos , Hipoglicemiantes/uso terapêutico , Adulto , Ilhas Atlânticas/epidemiologia , Feminino , Humanos , Insulina/uso terapêutico , Masculino , Pessoa de Meia-Idade , Prevalência , Espanha/epidemiologia
2.
An. med. interna (Madr., 1983) ; 17(11): 595-596, nov. 2000. ilus
Artigo em Es | IBECS | ID: ibc-234

RESUMO

Se define el síndrome de secreción ectópica de ACTH "oculto" como el hipercortisolismo dependiente de ACTH de origen extrahipofisario, sin que tras más de 6 meses se descubra su origen. Presentamos una paciente de 55 años diagnosticada de síndrome de Cushing y tratada mediante suprarrenalectomía bilateral en la que se descubre el tumor carcinoide secretor de ACTH 20 años después (AU)


Assuntos
Feminino , Pessoa de Meia-Idade , Humanos , Síndrome de ACTH Ectópico , Carcinoma , Neoplasias Pulmonares , Síndrome de ACTH Ectópico
3.
An Med Interna ; 17(11): 595-6, 2000 Nov.
Artigo em Espanhol | MEDLINE | ID: mdl-11322033

RESUMO

The occult ectopic ACTH syndrome is ACTH-dependent hypercortisolemia of non pituitary origin, and of more than 6 months duration without the diagnosis of the origin. We report a 55 years old woman diagnosed of Cushing syndrome and treated by mean of bilateral adrenalectomy, in which is discovered an ACTH-secreting carcinoid tumor 20 years later.


Assuntos
Síndrome de ACTH Ectópico/diagnóstico , Feminino , Humanos , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...